Vaccines: chasing the dream

Nature. 2011 Jul 13;475(7355):S18-9. doi: 10.1038/475S18a.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / immunology
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / prevention & control*
  • Alzheimer Disease / therapy*
  • Alzheimer Vaccines / adverse effects
  • Alzheimer Vaccines / immunology*
  • Alzheimer Vaccines / therapeutic use*
  • Amyloid / antagonists & inhibitors
  • Amyloid / chemistry
  • Amyloid / immunology
  • Amyloid / metabolism
  • Amyloid beta-Peptides / adverse effects
  • Amyloid beta-Peptides / antagonists & inhibitors*
  • Amyloid beta-Peptides / chemistry
  • Amyloid beta-Peptides / immunology
  • Amyloid beta-Peptides / metabolism
  • Amyloid beta-Peptides / therapeutic use
  • Animals
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Clinical Trials as Topic
  • Humans
  • Immunoglobulins, Intravenous / economics
  • Immunoglobulins, Intravenous / immunology*
  • Immunoglobulins, Intravenous / therapeutic use*
  • Mice
  • tau Proteins / antagonists & inhibitors
  • tau Proteins / chemistry
  • tau Proteins / metabolism

Substances

  • AN-1792
  • Alzheimer Vaccines
  • Amyloid
  • Amyloid beta-Peptides
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunoglobulins, Intravenous
  • tau Proteins
  • bapineuzumab